Life Science Compliance Update

October

2016

October 2016: Life Science Compliance Update

Written by , Posted in October 2016 LSC Update, This Month in Compliance

The full text of the entire issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.


   or   

October 2016 LSCU Cover

Issue Summary

We have experienced yet another busy compliance month on a variety of fronts. This month’s issue reflects that. Our feature article is from Tom Gregory of Ernest & Young on compliance issues with hub services. Chris Cobourn from Huron Life Science finishes up his excellent three-part series on AMP. King and Spalding Germany reflects on the risks of EFPIA disclosure and the enforcement section reports on several notable state and local efforts.


Feature Article

Arrow

Getting to the Hub of the Matter – Analyzing the Compliance Needs for Hub Services
Tom Gregory, Partner, Fraud Investigation & Dispute Services, Ernst & Young LLP
Abstract

Issue Articles

Arrow

What You Don’t Know About AMP Can Hurt You – Part 3 Can You Defend Your AMP?
Chris Cobourn, Managing Director, Huron Life Sciences
Abstract

Global Issues

Arrow

EFPIA HCP Financial Disclosure Is Not Risk Free
Ulf H. Grundmann, Partner, King & Spalding LLP, Frankfurt a.M. (Germany) and Elisabeth Kohoutek, Associate, King & Spalding LLP, Frankfurt a.M. (Germany)
Abstract

Arrow

Opioids Under the Microscope – A Recap of Recent Events that Could Substantially Impact Compliance
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer for Life Science Compliance Update
Abstract

Arrow

NPAs and DPAs – An Enforcement Loophole or Compliance Incentive?
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

How Realistic is the Yates Memo after Acclarent?
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer for Life Science Compliance Update
Abstract

Arrow

BMS Settles with California Insurance Commission – Seems Everyone Is Getting Into the Act
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer for Life Science Compliance Update
Abstract

Arrow

The Blue Ribbon Panel Raises the Bar on Ethics & Compliance
Calisha Myers, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Helping the Patient – Co-Pay Reimbursement Can Be Okay in Certain Circumstances
Robert N. Wilkey, Esq., Staff Writer and Seth Whitelaw, Editor, for Life Science Compliance Update
Abstract

Arrow

Like Taxes and Inflation – HHS Revises Civil Monetary Penalties Upwards
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer for Life Science Compliance Update
Abstract

Menu Title